"India should resist removing any flexibility because any trade agreement which could lead to India not being able to produce will be terrible for the rest of the world," said Michel Sidibe, executive director for the Joint United Nations Program on HIV/AIDS (UNAIDS).



"Millions of people will die if India cannot produce and Africa will be the most affected. For me, it is an issue of life or death," he told Reuters in an interview, adding that about 86 percent of people on treatment were taking drugs made in India.


The EU-India trade deal includes measures that could delay or restrict competition from generic medicines by extending patent terms, requiring data exclusivity and tightening border enforcement rules.


Such moves could drive up prices for India's anti-retroviral treatments, limit dosage options and delay access to newer and better drugs, said a UN report in September last year.



 <a href="http://www.montrealgazette.com/health/sexual-health/Millions+will+India+stops+AIDS+drugs/5053024/story.html#ixzz1SCYu8wF5" target="_blank" class="news_link">Read it all here</a>

Millions will die if India stops AIDS drugs: UN